These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8644929)

  • 21. Evaluation of regional liver damage by magnetic resonance imaging with superparamagnetic iron oxide in rat liver.
    Murakami T; Kim T; Takamura M; Shimizu J; Hori M; Dono K; Takachi K; Kato N; Miyazawa T; Sakon M; Monden M; Nakamura H
    Dig Dis Sci; 2001 Jan; 46(1):148-55. PubMed ID: 11270779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
    Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
    J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).
    Smith BR; Heverhagen J; Knopp M; Schmalbrock P; Shapiro J; Shiomi M; Moldovan NI; Ferrari M; Lee SC
    Biomed Microdevices; 2007 Oct; 9(5):719-27. PubMed ID: 17562181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential magnetic resonance imaging for evaluation of Kupffer cell function.
    Saito T; Abe T; Tsuchiya T; Satoh Y; Kenjo A; Kimura T; Gotoh M
    Hepatogastroenterology; 2008; 55(82-83):596-9. PubMed ID: 18613415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study].
    Yoshikawa K; Sasaki Y; Ogawa N; Sakuma S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb; 54(2):137-53. PubMed ID: 8121779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
    J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
    [No Abstract]   [Full Text] [Related]  

  • 28. [Three-dimensional MR angiography of HCC and portal and hepatic veins using superparamagnetic iron oxide].
    Ono Y; Marukawa T; Ashikaga R; Inoue M; Fujii K; Araki Y; Ishida O
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Feb; 58(3):97-8. PubMed ID: 9558852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.
    Chen F; Ward J; Robinson PJ
    Magn Reson Imaging; 1999 May; 17(4):549-56. PubMed ID: 10231181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
    Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
    J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of intrarenal distribution of ultrasmall superparamagnetic iron oxide particles by magnetic resonance imaging and modification by furosemide and water restriction.
    Trillaud H; Degrèze P; Combe C; Palussière J; Chambon C; Grenier N
    Invest Radiol; 1994 May; 29(5):540-6. PubMed ID: 8077093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early radiation effects on the liver demonstrated on superparamegnetic iron oxide-enhanced T1-weighted MRI.
    Mori H; Yoshioka H; Ahmadi T; Saida Y; Ohara K; Itai Y
    J Comput Assist Tomogr; 2000; 24(4):648-51. PubMed ID: 10966203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of iron oxide particles around liver metastases during MR imaging.
    Hahn PF; Stark DD; Ferrucci JT
    Gastrointest Radiol; 1992; 17(2):173-4. PubMed ID: 1551515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide.
    Mayo-Smith WW; Saini S; Slater G; Kaufman JA; Sharma P; Hahn PF
    AJR Am J Roentgenol; 1996 Jan; 166(1):73-7. PubMed ID: 8571910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients].
    Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE
    Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects.
    Clément O; Siauve N; Cuénod CA; Frija G
    Top Magn Reson Imaging; 1998 Jun; 9(3):167-82. PubMed ID: 9621405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.